As of 2024-12-15, the Intrinsic Value of Aurinia Pharmaceuticals Inc (AUP.TO) is (83.32) CAD. This AUP.TO valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 16.76 CAD, the upside of Aurinia Pharmaceuticals Inc is -597.10%.
The range of the Intrinsic Value is (472.82) - (46.43) CAD
Note: result may not be accurate due to the invalid valuation result of DCF model.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | (472.82) - (46.43) | (83.32) | -597.1% |
| DCF (Growth 10y) | (54.15) - (514.41) | (94.04) | -661.1% |
| Fair Value | -5.67 - -5.67 | -5.67 | -133.84% |
| EPV | (11.76) - (13.60) | (12.68) | -175.6% |
| DDM - Stable | (29.04) - (584.46) | (306.75) | -1930.3% |
| DDM - Multi | (29.98) - (467.64) | (56.26) | -435.7% |
| Market Cap (mil) | 2,147.89 |
| Beta | 0.35 |
| Outstanding shares (mil) | 128.16 |
| Enterprise Value (mil) | 1,926.18 |
| Market risk premium | 4.74% |
| Cost of Equity | 5.60% |
| Cost of Debt | 5.00% |
| WACC | 5.30% |